Detalles de la búsqueda
1.
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists.
Histopathology
; 84(3): 429-439, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957137
2.
Retraction: Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.
Nature
; 547(7662): 246, 2017 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28703201
3.
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
BMC Cancer
; 22(1): 625, 2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672677
4.
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.
Future Oncol
; 17(30): 4011-4025, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34337973
5.
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Oncologist
; 23(9): 1092-1102, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29700210
6.
Pan-TRK Immunohistochemistry to Optimize the Detection of NTRK Fusions: Removing the Hay When Looking for the Needle.
Mod Pathol
; 36(12): 100346, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37757968
7.
Aligning digital CD8+ scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma.
Histopathology
; 72(2): 270-284, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28815764
8.
Biological therapies in nonsmall cell lung cancer.
Eur Respir J
; 49(3)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28254765
9.
Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms.
Mod Pathol
; 35(12): 1754-1756, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207496
10.
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
Clin Chem
; 63(3): 751-760, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28073897
11.
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.
Thorax
; 71(2): 177-84, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26530085
12.
Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ.
Breast Cancer Res
; 16(4): R76, 2014 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186428
13.
NTRK gene fusion testing and management in lung cancer.
Cancer Treat Rev
; 127: 102733, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733648
14.
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation.
Arch Pathol Lab Med
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625026
15.
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
Arch Pathol Lab Med
; 148(3): 318-326, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37270803
16.
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries.
Lancet Reg Health Eur
; 38: 100838, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38476742
17.
RET Fusion Testing in Patients With NSCLC: The RETING Study.
JTO Clin Res Rep
; 5(4): 100653, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38525319
18.
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Clin Cancer Res
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630755
19.
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer.
Int J Cancer
; 133(4): 898-907, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23400671
20.
The ALK translocation in advanced non-small-cell lung carcinomas: preapproval testing experience at a single cancer centre.
Histopathology
; 62(4): 609-16, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23379755